Long-term treatment with growth hormone in short children with nephropathic cystinosis

Journal of Pediatrics

Volumn 138, Issue 6, 2001, Pages 880-887

  Wühl, Elke ^a,b,c,d   Haffner, Dieter ^a,b,c,d   Offner, G ^a,b,c,d   Broyer, Michel ^a,b,c,d   Hoff, William Van't ^a,b,c,d   Mehls, Otto ^a,b,c,d  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; MERCAPTAMINE;

ADOLESCENT; ADULT; ARTICLE; BODY HEIGHT; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTINOSIS; DIALYSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GROWTH RETARDATION; HUMAN; KIDNEY TRANSPLANTATION; MALE; NEPHROPATHIC CYSTINOSIS; NUTRITION; PREPUBERTY; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0034971459     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2001.113263     Document Type: Article

References (40)

1. Linkage of the gene for cystinosis to markers on the short arm of chromosome 17
2. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis
3. Infantile cystinosis: A reappraisal of early and late symptoms
4. Cysteamine therapy for children with nephropathic cystinosis
5. Growth and pubertal development in nephropathic cystinosis
6. Late symptoms in infantile cystinosis
7. Combined report on regular dialysis and transplantation in Europe, 1989
8. Lysosomal transport disorders: Cystinosis and sialic acid storage disorders
9. Improved renal function in children with cystinosis treated with cysteamine
10. The treatment of cystinosis with cysteamine and phosphocysteamine in the United Kingdom and Eire
11. Factors predictive of the short- and long-term efficacy of growth hormone treatment in prepubertal children with chronic renal failure
12. Long-term treatment of growth retarded children with chronic renal insufficiency, with recombinant human growth hormone
13. Effect of growth hormone treatment on adult height of children with chronic renal failure
14. Nephropathic cystinosis: Improved linear growth after treatment with recombinant human growth hormone
15. Growth in children with nephropathic cystinosis
16. Treatment with recombinant human growth hormone in short children with nephropathic cystinosis: No evidence for increased deterioration rate of renal function
17. Physical growth in swiss children from birth to 20 years of age
18. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine
19. Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus
20. Metabolic effects of long-term growth hormone treatment in prepubertal children with chronic renal failure and after kidney transplantation
21. Effect of growth hormone treatment on pubertal growth in a boy with cystinosis and growth failure after renal transplantation
22. Effect of growth hormone treatment on serum creatinine concentration in patients with cystinosis and chronic renal disease
23. Progression of chronic renal failure in a historical group of patients with nephropathic cystinosis
24. Is there an auxological basis for growth-promoting treatment with human growth hormone in short children?
25. Growth and development of nondialyzed children with chronic renal failure
26. Chronic renal failure and growth
27. Growth charts for prepubertal children with chronic renal failure due to congenital renal disorders
28. Growth after discontinuation of recombinant human growth hormone therapy in children with chronic renal insufficiency
29. Serum insulin-like growth factors (IGFs) and IGF binding proteins 1,2 and 3 in children with chronic renal failure: Relationship to height and glomerular filtration rate
30. Factors predictive of sustained growth in children after renal transplantation. The North American Pediatric Renal Transplant Cooperative Study
31. Final height and its predictive factors after renal transplantation in childhood
32. Growth hormone treatment in growth-retarded adolescents after renal transplant
33. Papilledema in 15 renally compromised patients treated with growth hormone
34. Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment
35. Growth hormone treatment of children with short stature increases insulin secretion but does not impair glucose disposal
36. Slowly deteriorating insulin secretion and C-peptide production characterizes diabetes mellitus in infantile cystinosis
37. Effect of growth hormone treatment on glucose tolerance in a patient with cystinosis after kidney transplantation
38. Diabetes mellitus in patients with infantile cystinosis after renal transplantation
39. Reversible diabetes mellitus during growth hormone therapy in chronic renal failure
40. Diabetes mellitus after therapy with recombinant human growth hormone